{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:45:39Z","timestamp":1761540339815,"version":"3.30.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2001,4,1]],"date-time":"2001-04-01T00:00:00Z","timestamp":986083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":6855,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2001,4]]},"DOI":"10.1023\/a:1011163211802","type":"journal-article","created":{"date-parts":[[2002,12,23]],"date-time":"2002-12-23T08:43:03Z","timestamp":1040632983000},"page":"525-533","source":"Crossref","is-referenced-by-count":39,"title":["c-erbB-2 oncoprotein overexpression identifies a subgroup of estrogen receptor positive (ER +) breast cancer patients with poor prognosis"],"prefix":"10.1016","volume":"12","author":[{"given":"A.E.","family":"Pinto","sequence":"first","affiliation":[]},{"given":"S.","family":"Andr\u00e9","sequence":"additional","affiliation":[]},{"given":"T.","family":"Pereira","sequence":"additional","affiliation":[]},{"given":"S.","family":"N\u00f3brega","sequence":"additional","affiliation":[]},{"given":"J.","family":"Soares","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"year":"1992","series-title":"Pathology of Breast","author":"Tavassoli","key":"10.1023\/A:1011163211802_bb0010"},{"key":"10.1023\/A:1011163211802_bb0015","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1093\/jnci\/85.15.1206","article-title":"Evaluating the potential usefulness of new prognostic and predictive indicators in node-negative breast cancer patients","volume":"85","author":"Gasparini","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1023\/A:1011163211802_bb0020","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/cncr.2820741326","article-title":"Prognostic factors in early breast carcinoma","volume":"74","author":"Mansour","year":"1994","journal-title":"Cancer"},{"key":"10.1023\/A:1011163211802_bb0025","first-page":"155","article-title":"Prognostic and predictive factors in breast cancer by immunohistochemical analysis","volume":"11","author":"Allred","year":"1998","journal-title":"Mod Pathol"},{"key":"10.1023\/A:1011163211802_bb0030","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1128\/MCB.6.5.1729","article-title":"p185, a product of the neu proto-oncogene, is a receptor-like protein associated with tyrosine kinase activity","volume":"6","author":"Stern","year":"1986","journal-title":"Mol Cell Biol"},{"issue":"Suppl 12","key":"10.1023\/A:1011163211802_bb0035","first-page":"51","article-title":"Basic science of HER-2\/neu A review","volume":"26","author":"Hung","year":"1999","journal-title":"Semin Oncol"},{"key":"10.1023\/A:1011163211802_bb0040","first-page":"827","article-title":"Evaluation of HER-2\/neu (erbB-2) status in breast cancer From bench to bedside","volume":"12","author":"Hanna","year":"1999","journal-title":"Mod Pathol"},{"key":"10.1023\/A:1011163211802_bb0045","first-page":"3260","article-title":"c-erbB-2\/neu overexpression enhances metastatic potential of human lung cancer cells by induction of metastasis-associated properties","volume":"54","author":"Yu","year":"1994","journal-title":"Cancer Res"},{"key":"10.1023\/A:1011163211802_bb0050","first-page":"815","article-title":"Expression of c-erb B-2 protein and DNA ploidy in breast carcinogenesis","volume":"119","author":"Schmitt","year":"1995","journal-title":"Arch Pathol Lab Med"},{"key":"10.1023\/A:1011163211802_bb0055","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1126\/science.3798106","article-title":"Human breast cancer Correlation of relapse and survival with amplification of HER-2\/neu oncogene","volume":"235","author":"Slamon","year":"1987","journal-title":"Science"},{"key":"10.1023\/A:1011163211802_bb0060","first-page":"4332","article-title":"HER-2\/neu amplification predicts poor survival in node-positive breast cancer","volume":"50","author":"Borg","year":"1990","journal-title":"Cancer Res"},{"key":"10.1023\/A:1011163211802_bb0065","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/bjc.1991.101","article-title":"c-erbB-2 oncoprotein expression in primary and advanced breast cancer","volume":"63","author":"Lovekin","year":"1991","journal-title":"Br J Cancer"},{"key":"10.1023\/A:1011163211802_bb0070","first-page":"3296","article-title":"Prognostic significance of c-erbB-2 and estrogen receptor status in human breast cancer","volume":"51","author":"McCann","year":"1991","journal-title":"Cancer Res"},{"key":"10.1023\/A:1011163211802_bb0075","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/ijc.2910490504","article-title":"Association of c-erbB-2 protein over-expression with high rate of cell proliferation, increased risk of visceral metastasis and poor long-term survival in breast cancer","volume":"49","author":"Kallioniemi","year":"1991","journal-title":"Int J Cancer"},{"key":"10.1023\/A:1011163211802_bb0080","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/oxfordjournals.annonc.a057824","article-title":"Association of c-erbB-2 expression and S-phase fraction in the prognosis of node positive breast cancer","volume":"2","author":"Anbazhagan","year":"1991","journal-title":"Ann Oncol"},{"key":"10.1023\/A:1011163211802_bb0085","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1200\/JCO.1992.10.7.1049","article-title":"Prognostic importance of c-erbB-2 expression in breast cancer","volume":"10","author":"Gusterson","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1011163211802_bb0090","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1002\/1097-0142(19940501)73:9<2359::AID-CNCR2820730919>3.0.CO;2-9","article-title":"Prognostic significance of HER-2\/neu oncoprotein expression in node-positive breast cancer The influence of the pattern of immunostaining and adjuvant therapy","volume":"73","author":"Tetu","year":"1994","journal-title":"Cancer"},{"key":"10.1023\/A:1011163211802_bb0095","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1200\/JCO.1998.16.4.1340","article-title":"neu\/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer","volume":"16","author":"Andrulis","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1011163211802_bb0100","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1200\/JCO.1996.14.10.2702","article-title":"c-erbB-2 overexpression decreases the benefit of adjuvant tamoxifen in early-stage breast cancer without axillary lymph node metastases","volume":"14","author":"Carlomagno","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1011163211802_bb0105","first-page":"1643","article-title":"Expression of epidermal growth factor receptor and c-erbB2 during the development of tamoxifen resistance in human breast cancer","volume":"3","author":"Newby","year":"1997","journal-title":"Clin Cancer Res"},{"key":"10.1023\/A:1011163211802_bb0110","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1200\/JCO.1992.10.4.599","article-title":"HRE-2\/neu in node-negative breast cancer Prognostic significance of overexpression influenced by the presence of in situ carcinoma","volume":"10","author":"Allred","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1011163211802_bb0115","first-page":"4140","article-title":"Genetic alterations in ER BB2-amplified breast carcinomas","volume":"5","author":"Isola","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1023\/A:1011163211802_bb0120","series-title":"Manual for Staging of Cancer","first-page":"171","author":"Beahrs","year":"1997"},{"key":"10.1023\/A:1011163211802_bb0125","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2559.1991.tb00229.x","article-title":"Pathological prognostic factors in breast cancer I The value of histological grade in breast cancer Experience from a large study with long-term follow-up","volume":"19","author":"Elston","year":"1991","journal-title":"Histopathology"},{"key":"10.1023\/A:1011163211802_bb0130","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/ajcp\/75.6.816","article-title":"The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase technics","volume":"75","author":"Hsu","year":"1981","journal-title":"Am J Clin Pathol"},{"key":"10.1023\/A:1011163211802_bb0135","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1136\/jcp.52.8.604","article-title":"Short term significance of DNA ploidy and cell proliferation in breast carcinoma A multivariate analysis of prognostic markers in a series of 308 patients","volume":"52","author":"Pinto","year":"1999","journal-title":"J Clin Pathol"},{"key":"10.1023\/A:1011163211802_bb0140","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/path.1711730413","article-title":"Brief, high-temperature heat denaturation (pressure cooking) A simple and effective method of antigen retrieval for routinely processed tissues","volume":"173","author":"Norton","year":"1994","journal-title":"J Pathol"},{"key":"10.1023\/A:1011163211802_bb0145","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1083\/jcb.60.2.523","article-title":"Mathematical analysis of DNA distributions derived from flow microfluorometry","volume":"60","author":"Dean","year":"1974","journal-title":"J Cell Biol"},{"key":"10.1023\/A:1011163211802_bb0150","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0046-8177(96)90161-6","article-title":"Interlaboratory reproducibility of semi-automated cell cycle analysis of flow cytometric DNA-histograms obtained from fresh material of 1295 breast cancer cases","volume":"27","author":"Bergers","year":"1996","journal-title":"Hum Pathol"},{"key":"10.1023\/A:1011163211802_bb0155","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/cyto.990140503","article-title":"Guidelines for implementation of clinical DNA cytometry","volume":"14","author":"Shankey","year":"1993","journal-title":"Cytometry"},{"key":"10.1023\/A:1011163211802_bb0160","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1023\/A:1011163211802_bb0165","first-page":"163","article-title":"Evaluation of survival data and two new rank order statistics arising in its consideration","volume":"50","author":"Mantel","year":"1966","journal-title":"Cancer Chemother Rep"},{"key":"10.1023\/A:1011163211802_bb0170","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc B"},{"key":"10.1023\/A:1011163211802_bb0175","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1200\/JCO.1998.16.2.462","article-title":"Prognostic and predictive value of c-erbB-2 overexpression in primary breast cancer, alone and in combination with other prognostic markers","volume":"16","author":"Sj\u00f6gren","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1011163211802_bb0180","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1200\/JCO.1992.10.5.686","article-title":"Human breast cancer Prognostic significance of the c-erbB-2 oncoprotein compared with epidermal growth factor receptor, DNA ploidy, and conventional pathologic features","volume":"10","author":"Gasparini","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1011163211802_bb0185","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/(SICI)1097-0142(20000215)88:4<804::AID-CNCR11>3.0.CO;2-Y","article-title":"The prognostic value of p53 and c-erbB-2 immunostaining is overrated for patients with lymph node negative breast carcinoma A multivariate analysis of prognostic factors in 613 patients with a follow-up of 14\u201330 years","volume":"88","author":"Reed","year":"2000","journal-title":"Cancer"},{"key":"10.1023\/A:1011163211802_bb0190","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1309\/LTUM-QG95-YRY3-L96U","article-title":"Immunohistochemical determination of HER-2\/neu expression in invasive breast carcinoma","volume":"113","author":"Vang","year":"2000","journal-title":"Am J Clin Pathol"},{"key":"10.1023\/A:1011163211802_bb0195","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3233\/BD-1999-11107","article-title":"HER2 testing Laboratory, technical and clinical considerations","volume":"11","author":"Dressler","year":"2000","journal-title":"Breast Dis"},{"key":"10.1023\/A:1011163211802_bb0200","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/jnci\/84.16.1279","article-title":"Correlation of HER-2\/neu amplification with expression and with other prognostic factors in 1103 breast cancers","volume":"84","author":"Ciocca","year":"1992","journal-title":"J Natl Cancer Inst"},{"key":"10.1023\/A:1011163211802_bb0205","first-page":"2087","article-title":"Expression of c-erbB-2 oncoprotein A prognostic indicator in human breast cancer","volume":"49","author":"Wright","year":"1989","journal-title":"Cancer Res"},{"key":"10.1023\/A:1011163211802_bb0210","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1200\/JCO.1990.8.1.103","article-title":"Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project Prognostic significance of erbB-2 protein overexpression in primary breast cancer","volume":"8","author":"Paik","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1011163211802_bb0215","first-page":"466","article-title":"Immunohistochemical assay of neu\/c-erbB-2 oncogene product in paraffin-embedded tissues in early breast cancer Retrospective follow-up study of 245 stage I and II cases","volume":"4","author":"Battifora","year":"1991","journal-title":"Mod Pathol"},{"key":"10.1023\/A:1011163211802_bb0220","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1002\/1097-0142(19950315)75:6<1320::AID-CNCR2820750614>3.0.CO;2-C","article-title":"Immunohistochemical detection of HER2\/neu in patients with axillary lymph node negative breast carcinoma A study of epidemiologic risk factors, histologic features, and prognosis","volume":"75","author":"Rosen","year":"1995","journal-title":"Cancer"},{"key":"10.1023\/A:1011163211802_bb0225","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/bjc.1991.78","article-title":"c-erbB-2 oncogene as a prognostic marker in breast cancer","volume":"63","author":"Perren","year":"1991","journal-title":"Br J Cancer"},{"key":"10.1023\/A:1011163211802_bb0230","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF01961241","article-title":"Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2\/neu","volume":"24","author":"Benz","year":"1992","journal-title":"Breast Cancer Res Treat"},{"key":"10.1023\/A:1011163211802_bb0235","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF00665783","article-title":"MCF-7 breast cancer cells overexpressing transfected c-erbB-2 have an in vitro growth advantage in estrogen-depleted conditions and reduced estrogen-dependence and tamoxifen-sensitivity in vivo","volume":"34","author":"Liu","year":"1995","journal-title":"Breast Cancer Res Treat"},{"key":"10.1023\/A:1011163211802_bb0240","first-page":"137","article-title":"erbB-2 amplification in breast cancer with a high rate of proliferation","volume":"6","author":"Borg","year":"1991","journal-title":"Oncogene"},{"key":"10.1023\/A:1011163211802_bb0245","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1038\/bjc.1995.497","article-title":"Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first-line hormonal therapy","volume":"72","author":"Archer","year":"1995","journal-title":"Br J Cancer"},{"key":"10.1023\/A:1011163211802_bb0250","first-page":"7","article-title":"HER-2 expression and response to tamoxifen in estrogen receptor-positive breast cancer A southwest oncology group study","volume":"4","author":"Elledge","year":"1998","journal-title":"Clin Cancer Res"},{"key":"10.1023\/A:1011163211802_bb0255","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1093\/jnci\/90.18.1320","article-title":"Should selection of adjuvant chemotherapy for patients with breast cancer be based on erbB-2 status?","volume":"90","author":"Clark","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1023\/A:1011163211802_bb0260","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1200\/JCO.1998.16.8.2659","article-title":"Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185 HER-2\/neu monoclonal antibody plus cisplatin in patients with HER-2\/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment","volume":"16","author":"Pegram","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1011163211802_bb0265","first-page":"260","article-title":"Anti-HER2 antibody and heregulin suppress growth of HER2-overexpressing human breast cancer cells through different mechanisms","volume":"6","author":"Le","year":"2000","journal-title":"Clin Cancer Res"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419540844?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419540844?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/12\/4\/525\/19479188\/12-4-525.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T09:27:31Z","timestamp":1733563651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419540844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,4]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,4]]}},"alternative-id":["S0923753419540844"],"URL":"https:\/\/doi.org\/10.1023\/a:1011163211802","relation":{},"ISSN":["0923-7534"],"issn-type":[{"type":"print","value":"0923-7534"}],"subject":[],"published":{"date-parts":[[2001,4]]}}}